1 min read Alzheimer's Health Pro-Science Lilly drug slows Alzheimer’s by 60% for mildly impaired patients in trial newsfactsnetwork July 17, 2023 Eli Lilly’s experimental drug donanemab slowed the progression of Alzheimer’s by 60% for patients in...Read More
